Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03206203
Title Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Vanderbilt-Ingram Cancer Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Georgetown University Lombardi Comprehensive Cancer Center Washington District of Columbia 20057 United States Details
Indiana University Health Melvin Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland 21231 United States Details
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field